Vir Biotechnology Announces Multiple Abstracts Highlighting

– Data support the potential impact of VIR-2218 and VIR-3434 in addressing both HBV and HDV and underscore the Company’s confidence in its approach to a functional cure for HBV – SAN... | June 7, 2023

Related Keywords

United States , Auckland , New Zealand , Vienna , Wien , Austria , Florian Lempp , Snehav Gupta , Fung Yuen , Edward Gane , Marka Schmidt , Key Laboratory Of Liver Research , Vir Biotechnology Inc , Kaiser Permanente Center , Head Of Research , Nasdaq , Alnylam Pharmaceuticals Inc , University Of Auckland , Health Research , School Of Clinical Medicine , University Of Hong Kong , European Association , Phil Pang , Executive Vice President , Chief Medical Officer , Interim Head , American Association , Liver Diseases , Oral Presentation , Man Fung Yuen , Queen Mary Hospital , Clinical Medicine , State Key Laboratory , Liver Research , Chief Hepatologist , Transplant Physician , Deputy Director , New Zealand Liver Transplant Unit , Auckland City , Clinical Pharmacology , Enhanced Stabilization Chemistry Plus , Alnylam Pharmaceuticals , Vir Biotechnology , Nc Stock Exchange , News , Information , Press Release , Data , Support , The , Potential , Impact , F , End , N , Ddressing , Moth , Gbv , Dv , Underscore , Confidence , Its , Approach , O , Unctional , Cure , Or , Bv Vir Us92764n1028 ,